Our current study is merely a descriptive and associative investigation of SERPINE1 expression to determine the association with gastric cancer progression and prognosis, which has led to some limitations, such as calculating the cut-off point and high vs. low SERPINE1 expression. The gene discussed is SERPINE1; the disease is gastric cancer.